- Home
- Latest
- By speciality
- Policy
- Biology
- Bone
- Brain and nervous system
- Breast
- Colorectal and gastrointestinal
- Community
- Diagnostics
- Drug development
- Epidemiology and prevention
- Haematology oncology
- Head and neck
- Hepatobiliary pancreatic
- Lung and pleura
- Melanoma and skin
- Ovary and gynaecology
- Paediatric
- Prostate and urology
- Psycho social
- Radiotherapy
- Sarcomas
- Surgery
- Other
- By congress
- By continent
- Latest technologies
- Education
- Most viewed
- View all
Latest
Flash player required
You do not have the correct version of the flash player required to view this content. Click here to install the free Adobe flash player.
Dr Patrick Hwu - M.D. Anderson Cancer Center, US
Therapeutic vaccine improves response rate and extends progression-free survival in patients with metastatic melanoma
Patrick Hwu, MD, Chair of the Department of Melanoma Medical Oncology M. D. Anderson Cancer Center: Therapeutic Vaccine Improves Response Rate and Extends Progression-Free Survival in Patients with Metastatic Melanoma: Preliminary findings from a phase III, multicenter trial show that adding a novel cancer vaccine – called gp100:209-217(210M) peptide – to standard therapy doubles response rates and extends progression-free survival in patients with metastatic melanoma, without causing significant side effects.
Congress » ASCO 2009
Other Congress
Content is the view and comment of the speakers or author and not of sponsoring companies or organisations. Organisation logo does not indicate endorsement.
Comments on this video Report unsuitable comment
No comments have been made on this video yet, be the first to voice your opinion, use the form on the right.
Add a comment